openPR Logo
Press release

What's Happening With Hemoglobinopathy Market? Key Players are Bio-Rad Laboratories, Danaher Corporation, Mindray Medical International, Nexcelom Bioscience, Abbott Diagnostics, Nihon Kohden Corporation, PerkinElmer, Siemens Healthineers

What's Happening With Hemoglobinopathy Market? Key Players

The global hemoglobinopathy market is segmented based on indication type, test type, end users, and region. Based on indication, the market is segmented into sickle cell disease, alpha thalassemia, and beta thalassemia. Beta thalassemia segment is expected to register a significant CAGR of 8.7% during the forecast period. Sickle cell disease segment is anticipated to grow with a CAGR of 8.3% over the forecast period.

The market has been segmented based on major types of diagnostic tests such as red blood cell (RBC) count test, genetic testing, hemoglobin by high performance liquid chromatography (HPLC) test, hemoglobin isoelectric (Hb IEF) focusing, hemoglobin electrophoresis (Hb ELP) test, and hemoglobin solubility test. The genetic testing segment is expected to expand at the highest CAGR of 9.2% over the forecast period due to increasing adoption of preventive measures such as genetic counseling and testing. Increasing popularity of prenatal and premarital genetic screening make these tests an attractive opportunity for market players.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/10007

Based on end users, the market has been segmented into hospitals, diagnostic laboratories, and clinics. The diagnostic laboratories segment is anticipated to account for the highest market share over the forecast period, registering a CAGR of 8.9% due to availability of dedicated equipment, reagents, and trained technicians required to perform rather complex diagnostic procedures like genetic testing, Hb HPLC, and isoelectric focusing.

The global hemoglobinopathy market has been segmented into five major regions: North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA). North America and Europe are expected to dominate the global hemoglobinopathy market with maximum market share in 2016. North America and Europe collectively have been expected to account for more than 50% of the total global hemoglobinopathy market share in terms of value in 2016. Among emerging markets, Asia Pacific is estimated to exhibit the highest CAGR of 9.3% over the forecast period, due to an increase in the diagnosis rate.

Hemoglobinopathy market is projected to register a healthy CAGR of 8.3% over the forecast period 2016 – 2024 owing to various factors, on which Persistence Market Research offers detailed insights.

Most health insurance companies, including government programs in the U.S. and Europe provide insurance coverage for hemoglobinopathy therapy under the CPT code. This creates a favorable environment for the growth of the global hemoglobinopathy market. Various government initiatives are being carried out for detection and management of hemoglobinopathy in high disease prevalence regions across the globe, giving a fillip to the global hemoglobinopathy market. Advancements in diagnosis techniques have led to the development of new tests that have enabled clinicians to provide effective diagnosis and therapeutic assistance to patients. Rising awareness about these disorders coupled with various public and private initiatives is also fueling the growth of the global hemoglobinopathy market in the regions with a high prevalence of sickle cell anemia and thalassemia.

Lack of awareness regarding hemoglobinopathy disorders among the populace especially in underdeveloped countries is a major factor hampering growth of the global hemoglobinopathy market. The lack of a permanent cure for hemoglobinopathy disorder is also one of the restraints affecting the global hemoglobinopathy market.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/10007

Some key players in the global hemoglobinopathy market identified in the report include Abbott Diagnostics, Bio-Rad Laboratories Inc., Danaher Corporation, Mindray Medical International Ltd., Nexcelom Bioscience LLC., Nihon Kohden Corporation, PerkinElmer Inc., Siemens Healthineers, and Sysmex Corporation.

The individual strategies of these companies in terms of increasing focus on rare diseases, initiatives to increase disease awareness, and enhancing distribution base have been discussed. The report concludes with strategic recommendations for players already present in the market and new players planning to enter the global hemoglobinopathy market, which could help them in the long run.

Table of Contents

1. Executive Summary
2. Market Taxonomy
3. Global Hemoglobinopathy Market Analysis Scenario
3.1. Pricing Analysis
3.1.1. Pricing Assumptions

3.1.2. Price Analysis per Region
3.2. Market Size (US$ Mn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
3.2.2. Absolute $ Opportunity
3.3. Market Overview
3.3.1. Global Hemoglobinopathy Market Reimbursement Scenario

4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side

4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Key Trends
4.6. Forecast Factors – Relevance and Impact

5. Global Hemoglobinopathy Market Analysis and Forecasts, by Indication
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis by Indication
5.3. Y-o-Y Growth Projections by Indication
5.4. Market Value Forecast, 2016–2024
5.4.1. Sickle Cell Disease
5.4.2. Beta Thalassemia
5.4.3. Alpha Thalassemia
5.5. Market Attractiveness by Indication

6. Global Hemoglobinopathy Market Analysis and Forecasts, by End User
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis by End User
6.3. Y-o-Y Growth Projections by End User

6.4. Market Value Forecast by End User, 2016–2024
6.4.1. Hospitals
6.4.2. Diagnostics Laboratories
6.4.3. Clinics
6.5. Market Attractiveness by End User

7. Global Hemoglobinopathy Market Analysis and Forecasts, by Test Type
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis by Test Type
7.3. Y-o-Y Growth Projections by Test Type
7.4. Market Value Forecast by Test Type, 2016–2024

7.4.1. Routine Red Blood Cell (RBC) Count
7.4.2. Genetic Testing
7.4.3. Hemoglobin by High Performance Liquid Chromatography
7.4.4. Hemoglobin Isoelectric Focusing (Hb IEF)
7.4.5. Hemoglobin electrophoresis (Hb ELP)
7.4.6. Hemoglobin Solubility Test
7.5. Market Attractiveness by Test Type

8. Global Hemoglobinopathy Market Analysis and Forecasts, by Region
8.1. Basis Point Share (BPS) Analysis by Country
8.2. Y-o-Y Growth Projections by Country
8.3. Market Value Forecast by Region
8.3.1. North America

8.3.2. Latin America
8.3.3. Europe
8.3.4. APAC
8.3.5. MEA
8.4. Market Attractiveness by Country

Buy Now @ https://www.persistencemarketresearch.com/checkout/10007

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's Happening With Hemoglobinopathy Market? Key Players are Bio-Rad Laboratories, Danaher Corporation, Mindray Medical International, Nexcelom Bioscience, Abbott Diagnostics, Nihon Kohden Corporation, PerkinElmer, Siemens Healthineers here

News-ID: 1762618 • Views: 132

More Releases from persistencemarketresearch.com

Sales of Body & extremities aesthetic procedure Market Market to Record Stellar …
Body & extremities aesthetic procedure is a cosmetic procedures involving the lower body and extremities through surgical and medical techniques for lifting, augmentation, reduction, or improvement of a body part. Both surgical and non-surgical strategies are thought to be suitable treatment choices for individuals who need to inculcate an instant change in their appearance. Body & extremities aesthetic procedure involves removing localized collections of fatty tissue or excess skin or
Global Electricity Transmission Towers Market Market to Witness Increased Revenu …
Global Electricity Transmission Towers Market: Introduction Electricity transmission towers are units that support power carrying conductors, i.e. overhead power lines between the generating end station and the local end substation. Electricity transmission towers play a vital role in delivering power through overhead lines by structurally supporting heavy high-voltage conductors. To transmit maximum power (110 kV or above) through overhead lines, typically towers have a height varying between 15 meters and 55
Companies in the Global Suspension Arm Market Market Resorting to Product Innova …
Global Suspension Arm Market: Overview The suspension system functions to reduce and prevent the road shocks and thereby deliver smooth drive experience. Suspension arm also called as wishbone suspension or track control arm are attached to the chassis of the vehicle and the wheels via the ball joint. The suspension arm is important in steering and change of direction while driving as they absorb the forces of road acting on the
Global Automatic Transmission Fluid (ATF) Market to Offer Increased Growth Prosp …
 Automatic Transmission Fluid (ATF) is a type of slippery liquid which act as a lubricant for easy movement of all moving parts inside a transmission system. Automatic transmission system is a more evolved and technically upgraded transmission system in comparison to manual transmission system as automatic transmission minuses human intervention of shifting gear with correspondence to speed. Automatic transmission system is a more complex system than manual transmission system and

All 5 Releases


More Releases for Hemoglobin

Global Hemoglobin Analyzers Market Research Report
This report studies the global Hemoglobin Analyzers market status and forecast, categorizes the global Hemoglobin Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report EKF Diagnostics HemoCue ManthaMed ApexBio Boditech Med Inc. CERAGEM Medisys DiaSys Diagnostic Systems GmbH Fenwal Fresenius Kabi
New Trends and Key Developments in Glycated Hemoglobin Testing Market
Global glycated hemoglobin testing market is projected to reach a valThe global glycated hemoglobin testing market is segmented on the basis of type, technique, end user, and region.ue of over US$ 650 Mn in 2026 at a CAGR of 8.6% over the forecast period. Glycated hemoglobin testing is used to measure concentration of blood glucose in individuals. HbA1c, is a chemical form of glycated hemoglobin, a protein within red blood
Global Hemoglobin Analyzer Market Insights, Forecast to 2025
This report studies the global market size of Hemoglobin Analyzer in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemoglobin Analyzer in these regions. This research report categorizes the global Hemoglobin Analyzer market by top players/brands, region, type and end user. This report also studies the global Hemoglobin Analyzer market status, competition landscape, market share, growth rate, future
Glycated Hemoglobin Testing Market: Prevalence of Diabetes to Bolster Demand for …
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.
Glycated Hemoglobin Testing Market: Prevalence of Diabetes to Bolster Demand for …
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.
Glycated Hemoglobin Testing Market 2017 Share, Trend, Segmentation and Forecast
Increasing incidences of diabetes have propelled the need for improved diagnostics in the global healthcare devices. Companies manufacturing critical diagnostic devices are focusing on facilitating products for effective tests. The use of glycated hemoglobin in diagnosis of diabetes mellitus continues to gain traction, creating a steady demand for glycated hemoglobin testing. Transparency Market Research’s recent report on the global glycated hemoglobin testing market delivers a forecast outlook on growing demand for these